HDFC Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1383 Cr | ₹3416 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 28 Sep 2023 | 31 Dec 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 32% |
| Expense Ratio | 2.17 | 1.95 |
| Manager | Dhruv Muchhal | Pradeep Kesavan |
| ISIN Code | INF179KC1HL7 | INF200K01446 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Month | -2.19% | -2.13% |
| 6 Month | 18.27% | 14.55% |
| 1 Year | 37.62% | 30.1% |
| 3 Year | - | 23.13% |
| 5 Year | - | 27.58% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 33.18% | 23.89% |
| 3 Year | - | 31.58% |
| 5 Year | - | 25.73% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| 1 Year | 62.28% | 14.51% |
| 3 Year | - | 17.07% |
| 5 Year | - | 12.42% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Standard Deviation | - | 14.02% |
| Sharp | - | 1.04% |
| Beta | - | 0.8% |
| Alpha | - | 5.51% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Name | Dhruv Muchhal | Pradeep Kesavan |
| Total AUM | ₹520687 Cr | ₹434274 Cr |
| Fund Manage | 40 | 43 |
| HDFC Pharma and Healthcare Fund - Regular (G) | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.98 | 7.82 |
| Small Cap | 33.12 | 37.28 |
| Large Cap | 32.5 | 30.06 |
| Mid Cap | 32.4 | 24.84 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
|---|---|---|
| Others | 1.98 | 7.82 |
| Pharmaceuticals & Biotechnology | 74.71 | 57.84 |
| Healthcare Services | 22.28 | 25.46 |
| Retailing | 1.03 | - |
| Chemicals & Petrochemicals | - | 3.5 |
| Healthcare Equipment & Supplies | - | 5.38 |
Top Comparisons
Kotak NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns18.73%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns5.65%
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.26%
UTI Arbitrage Fund - Regular Plan - Growth Option
3Y Returns6.33%
Franklin India Focused Equity Fund - Growth Plan
3Y Returns13.72%
Mirae Asset Focused Fund Regular Plan Growth
3Y Returns6.22%
ICICI Prudential Equity Arbitrage Fund - Growth
3Y Returns6.34%
Invesco India Arbitrage Fund - Growth Option
3Y Returns6.72%